Li, Yaping
Xu, Yongyi
Kang, Guangtao
Lan, Xinya
Lin, Zhonghua
Jiang, Cai
Funding for this research was provided by:
the Fujian Provincial Health Science and Technology Program (2024QNA009)
the 2022 General Project Plan of Fujian Medical University’s Qihang Fund (2022QH1328)
National Natural Science Foundation of China (81904271)
Joint Funds for the Innovation of Science and Technology of Fujian Province (2024Y9078)
Article History
Received: 16 December 2025
Accepted: 21 April 2026
First Online: 26 April 2026
Declarations
:
: The authors declare no competing interests.
: The datasets generated and/or analyzed during the current study are not publicly available due to privacy issues. However, data will be available upon formal request to the corresponding author.
: The project was approved by the Chinese Clinical Trial Registry (Registration No. ChiCTR2100041790; Initial registration date: 01/05/2021) and the Hospital Ethics Committee of Affiliated Provincial Hospital of Fuzhou University (No.2019-03-035). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.